Tag : Ebola outbreak 2014
Sort by: Newest first Oldest first A-Z Z-A
-
A pharmacist's journey through the Ebola epidemic
Pharmacist Claire Liew is currently volunteering at an Ebola treatment centre in Sierra Leone. She explains how the disease has affected everyday life.
-
A visual guide to the Ebola virus epidemic Subscription
As the 2014 Ebola virus epidemic continues to escalate, we chart the latest epidemiological data alongside an insight into the pathology of Ebola virus disease and the biological processes being targeted by drug and vaccine developers.
-
Ebola advice for NHS staff Subscription
The Department of Health and Public Health England have published a letter containing advice for healthcare professionals who want to volunteer to support those dealing with the outbreak of the Ebola virus in West Africa. The letter is available ...
-
Ebola clinical trial suspended after volunteers complain of joint pains Subscription
A phase I clinical trial of the fast-tracked Ebola vaccine VSV-ZEBOV has been halted in Switzerland because some trial participants developed mild joint pain.
-
Ebola research gets a 280m euro boost from EU and drug industry Video Subscription
The European Union has pledged 280m euro to a research project to develop vaccines and diagnostic tests for Ebola.
-
Ebola trials fast-tracked in Africa Subscription
Experimental drugs for Ebola are to be fast-tracked in clinical trials being set up in West African states that are fighting the epidemic.
-
Ebola update Subscription
The Department of Health has issued an update on the Ebola virus outbreak in West Africa, providing a reminder of the need to remain vigilant for cases imported to the UK. The update is available from the DH website.
-
Ebola vaccine hope Subscription
Researchers have successfully immunised mice against the deadly Ebola virus in the hope of developing a human vaccine. They used virus-like particles made of the Ebola virus’s two coat proteins. After exposure to the real virus, all of the immunised mice ...
-
Ebola vaccine tested in 60 volunteers shows immune response Subscription
An Ebola vaccine being developed by GlaxoSmithKline and the US National Institutes of Health is well tolerated and generates an immune response, according to initial testing of the vaccine in 60 healthy volunteers.
-
Ebola: what pharmacists need to know Subscription
Pharmacists are ideally placed to help educate the public during the current outbreak of Ebola virus disease.
Show 10 per page20 per page50 per page
